Robotic Radiotherapy Market

The global size of robotic radiotherapy market in terms of revenue was estimated to be worth $1.1 billion in 2023 and is poised to reach $1.9 billion by 2028, growing at a CAGR of 11.9% from 2023 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.

The market's expansion is driven by several factors, including the global rise in cancer cases, advancements in automation technologies enhancing the precision of radiotherapy, a growing preference for non-invasive cancer treatments, and the rapid proliferation of cancer treatment facilities. Additionally, increased merger and acquisition activities between manufacturers and radiotherapy software developers are expected to stimulate the uptake of radiotherapy systems. An illustrative example is the collaboration between GE Healthcare (US) and RaySearch Laboratories (Sweden) in May 2022 to pioneer a novel radiation therapy simulation and treatment planning workflow solution.

Furthermore, heightened government and private investments aimed at addressing the escalating need for cancer treatment, coupled with the rising healthcare expenditure and the burgeoning medical tourism sector in developing nations, are expected to present attractive growth prospects for stakeholders in the market in the foreseeable future.

Nevertheless, the substantial expense associated with radiotherapy systems may limit their availability in cancer centers, particularly in low-resource economies. Moreover, a scarcity of adequately trained personnel and the intricate nature of radiotherapy systems are anticipated to impede market expansion.

Global Robotic Radiotherapy Market Trends

To know about the assumptions considered for the study, Request for Free Sample Report

e- Estimated; p- Projected

Robotic Radiotherapy: Market Dynamics

Driver: Advancements in radiation therapy technologies

Technological progress has significantly transformed radiation therapy, resulting in the creation of sophisticated radiation therapy systems. These systems integrate advanced technologies and automation to enhance treatment efficiency, precision, and ultimately, patient outcomes.

The key technological advancement in radiation therapy involves the utilization of computerized treatment planning systems. These systems utilize algorithms and modeling techniques to create accurate treatment plans tailored to each patient. Through analysis of the patient's anatomy, tumor positioning, and radiation dosage needs, these automated systems optimize treatment plans, minimizing radiation exposure to healthy tissues and consequently lowering side effects. Some of the advancements are listed below:

• In 2023, MIM Software received FDA approval for its AI auto-contouring solution Contour ProtégéAI. This new software update offers improved algorithms for molecular radiotherapy and radiation oncology, further improving treatment outcomes.
• In May 2023, Brainlab AG launched the ExacTrac Dynamic Surface, a new product in the ExacTrac Dynamic product family of radiotherapy patient positioning and monitoring systems which is dedicated to surface-guided radiation therapy (SGRT).

In summary, technological advancements and automated systems in radiation therapy have revolutionized cancer treatment. As technology continues to advance, we can expect further innovations in robotic radiotherapy system, providing even more benefits for patients driven by the desire to offer patients less painless invasive, and more effective treatment options while reducing the risks and complications associated with traditional open surgeries.

Restraint: Dearth of skilled radiologists/oncologist

Robotic radiotherapy require radiologists to have a high level of expertise not only in radiation therapy but also in the use and interpretation of automated systems. These systems use complex algorithms and machine learning techniques to plan and deliver radiation treatments, and radiologists need to be well-versed in these technologies to effectively use these systems.

Unfortunately, there is a shortage of radiologists with the necessary skills and knowledge to work with radiotherapy systems. This is largely due to the lack of training opportunities and limited exposure to these systems during radiology education. Most radiology training programs focus on traditional radiation therapy techniques, and there is limited emphasis on the use of automated systems.

• The dearth of skilled radiologists has the potential to hinder the widespread adoption of radiotherapy systems. Healthcare facilities that invest in these systems may struggle to find qualified radiologists to operate them, limiting the benefits that these systems can provide.

Some of the related examples are mentioned below:

• The number of radiologists in the workforce is not growing as fast as the population and the demand for imaging. There’s absolutely a well-recognized shortage of radiologists in the U.K., Europe has 13 radiologists per 100,000 population but in the U.K., the rate is only 8.5 per 100,000.
• Similarly, India is also facing an acute shortage of oncologists, radiotherapists, and surgical oncologists. According to the Indian Council for Medical Research (ICMR), the number of Indians suffering from cancer is expected to increase to 29.8 million in the year 2025 from 26.7 million in 2021. However, the country has a huge shortfall of number of oncologists available for cancer patients. Currently, India has 200 oncologists per million cancer patients only.

By investing in the training and development of skilled radiologists, the robotic radiotherapy market can overcome the dearth of expertise and realize its full potential in improving cancer treatment outcomes.

Opportunity: Growing Government and Private Investments to Meet the Increasing Demand for Cancer Treatment

Radiotherapy has been accepted as a standard procedure for cancer treatment. The growing incidence of cancer and approval of different technologies for various radiation therapy applications are increasing the demand for radiotherapy procedures, globally. Currently, for every million people, there are almost 12 linear accelerators in the US, 5 to 8 radiotherapy machines in European countries, and less than one machine in developing countries across Asia, Latin America, and Africa. To bridge this gap, there is a requirement of over 10,000 more treatment machines, globally (Source: Cancer Control). Increasing public-private investments and funding for cancer research to bring in advancements in the diagnosis and treatment of cancer is one of the major factors supporting the growth of the robotic radiotherapy market. Listed below are some of the key developments in this regard:

• In July 2021, Leo Cancer Care (UK) successfully raised USD 25.3 million in funding from the investors across the globe taking an active interest in the businesses’ plan to develop upright radiotherapy solutions. The investors included Yu Galaxy, WARF, Alumni Ventures, Junson Capital and Serra Ventures, as well as industry players CHC, Cosylab, Toret Devices and Radiation Business Solutions.
• In August 2020, the Australian Government opened application for fundings of USD 45.5 million to develop regional radiation treatment centres for local cancer patients in rural and regional areas of New South Wales, Queensland, Victoria and South Australia.

Such investments from public and private sources are expected to offer potential growth opportunities for market players in the coming years.

Challenge: High cost of automated radiation therapy systems

Radiation therapy systems are highly sophisticated and require advanced technology and components. These systems must deliver precise and targeted radiation doses to minimize damage to healthy tissues while effectively treating tumors. Achieving this level of precision requires expensive machinery and software.

The cost of an radiotherapy system can vary depending on several factors, including the brand, model, features, and additional services. The high cost of automation radiation therapy systems can pose challenges for healthcare providers and patients, it is important to consider the value and benefits they offer in terms of improved treatment outcomes, enhanced precision, and reduced side effects. Continuous advancements in technology and growing market competition may also help drive down costs in the future.

Market Ecosystem

By product, the radiotherapy systems segment accounted for the largest share of robotic radiotherapy industry during the forecast period.

Based on the product, the robotic radiotherapy market is segmented into radiotherapy systems, software, 3D cameras, and others. The software segment accounted for the largest share of the global robotic radiotherapy market in 2022. Rapid penetration of AI in radiotherapy , increasing availability of radiation therapy software, and growing focus of market player on partnership & collaboration to enhance radiation software capabilities is supporting the overall growth of segment.

By technology, the linear accelerators segment accounted for the largest share of robotic radiotherapy industry during the forecast period.

Based on technology, the robotic radiotherapy market is segmented into linear accelerators, stereotactic radiation therapy systems, and particle therapy. The linear accelerators segment is expected to account for the for the largest share of robotic radiotherapy market owing to the availability of advanced systems and their growing adoption worldwide. Furthermore, oncologists are increasingly recognizing the advantages of MR LINAC, leading to heightened investments in research and development for automated LINAC technology. Collaborations between industry players and cancer institutes are also on the rise, aimed at fostering innovation and improving the accessibility of LINAC technology.

By application, lung cancer is expected to witness significant growth of robotic radiotherapy industry during the forecast period.

Based on application, the robotic radiotherapy market is segmented into prostate cancer, breast cancer, lung cancer, head & neck cancer, colorectal cancer, and other cancers. The lung cancer segment accounted for the largest share of the global robotic radiotherapy market in 2022. The rapid rise in lung cancer prevalence, coupled with a rising count of patients opting for radiotherapy, is expected to drive growth in this segment. As per the American Lung Association (ALA), approximately 237,000 individuals in the United States received a lung cancer diagnosis in 2022.

By End User, hospital segment to dominate robotic radiotherapy industry end user.

Based on end-user, the global robotic radiotherapy market is segmented into hospitals and independent radiotherapy centers. The Hospitals segment dominated the global robotic radiotherapy end-user market in 2022 owing to the increase in the cancer patients undergoing radiotherapy treatment in cancer hospitals, increasing partnerships between radiotherapy providers and hospitals, and the expansion of cancer hospitals in both developed and developing countries.

North America to account for the largest share of robotic radiotherapy industry during the forecast period.

To know about the assumptions considered for the study, download the pdf brochure

North America is the expected largest regional market for robotic radiotherapy products in the forecast period. Countries in this market are witnessing a high volume of radiotherapy procedures, robust healthcare infrastructure, extensive patient base, and continuous hospital investments in upgrading their facilities. These elements collectively contribute to the region's significant share in the field.

As of 2022, prominent players in the robotic radiotherapy market are Siemens Healthcare GmbH (Germany), Elekta (Sweden), Accuray Incorporated (US), IBA (Belgium), ViewRay Technologies, Inc. (US), C-RAD (Sweden), IBA Worldwide (Belgium), Hitachi Ltd. (Japan (US), Mevion Medical Systems (US), Optivus Proton Therapy, Inc. (US), Panacea Medical Technologies Pvt. Ltd. (India) and P-Cure (Israel), among others.

Scope of the Robotic Radiotherapy Industry

This report has segmented the global robotic radiotherapy market to forecast revenue and analyze trends in each of the following submarkets:

By Product

• Radiotherapy Systems
• Softwares
• 3D Cameras (Surface Guided)
• Others

By Technology

• Linear Accelerators
• Conventional Linear Accelerators
• MRI - Linear Accelerators
• Stereotactic Radiation Therapy Systems
• Cyberknife
• Gamma Knife
• Particle Therapy
• Proton Beam Therapy
• Heavy Ion beam Therapy

By Application

• Prostate Cancer
• Breast Cancer
• Lung Cancer
• Head & Neck Cancer
• Colorectal Cancer
• Other Cancers

By End User

• Hospitals
• Independent Radiotherapy Centers

By Region

• North America
  • US
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Rest of World

Recent Developments of Robotic Radiotherapy Industry:

• In May 2023, Vision RT (UK)received approval from FDA for the commercialization of its SGRT product Map RT in the US.
• In June 2023, RaySearch Laboratories (Sweden)launched RayStation 12A, an advanced treatment radiation treatment planning system.
• In February 2022, MIM Software formed a partnership with Genesis Care, one of the largest providers of cancer care services in Australia. Through this partnership, MIM Software will provide a comprehensive set of AI and automation radiotherapy software, including MIM Premier and MIM SurePlan MRT, across all the cancer treatment centers of GensisCare.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst